Teva Canada, Cobalt Labs Face Label Claims Over Generic Cipro

Teva Canada Ltd. and Cobalt Laboratories Inc. must keep facing some claims by a woman who alleges that they failed to timely update risk warnings on a generic ciprofloxacin antibiotic, a Minnesota federal court said.

Jennifer Akman alleges she suffered permanent nerve damage caused by taking the drug in November 2013. She says the companies failed to provide her and her physician with a warning approved by the Food and Drug Administration in August 2013 that described the risk of rapid onset nerve damage, and eliminated a statement saying neuropathy was a “rare” side effect.

State-law claims challenging current generic ...